CAS: 14611-51-9; Selegiline

结构式图片

欧盟法规

REACH注册C&L通报REACH预注册

上下游产品

methamphetamin 2-propynyl chloride 1-phenyl-acetone allylbenzene(-)-N,1-dimethyl-N-propargylphenylethylamine 19H26N4O4C19H26N4O4 (R)-(-)-deprenyl hydr°Chloride

合成工艺路线路线简述

    📜左苯丙胺置于lithium Aluminium Tetrahydride,Potassium Carbonate,三乙胺体系中,用 四氢呋喃,二氯甲烷,乙腈 用作溶剂,化学反应 17.0H,反应生成司来吉兰 盐酸盐
    参考文献:An Organo-Catalytic Approach To The Enantioselective Synthesis Of (R)-Selegiline
    标题:An Organo-Catalytic Approach To The Enantioselective Synthesis Of (R)-Selegiline
    摘要:An Efficient Enantioselective Synthesis Of (R)-Selegiline Has Been Achieved By Two Routes,Via Proline-Catalyzed Alpha-Aminooxylation As Well As Alpha-Amination Of Phenylpropanaldehyde As The Key Step. (C) 2007 Elsevier Ltd. All Rights Reserved.
    Doi:10.1016/j.Tet.2007.07.012

    海关参考信息

    专利信息


    专利号:US-9446995-B2
    优先权日:2012-05-21
    标 题:Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
    发明人:CHONG HYUN-SOON
    权利人:CHONG HYUN-SOON; ILLINOIS INST OF TECH
    摘要:Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.

    专利号:US-10189803-B2
    优先权日:2008-02-22
    标题 :Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
    发明人:CHONG HYUN-SOON
    权利人:CHONG HYUN SOON; ILLINOIS INSTITUTE OF TECH
    摘要:Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.

    专利号:US-6271379-B1
    优先权日:2000-03-08
    标题:Intermediates useful for the synthesis of huperzine A
    发明人:TUECKMANTEL WERNER; KOZIKOWSKI ALAN P
    权利人:UNIV GEORGETOWN
    摘要:Intermediates useful for the synthesis of huperzine A represented by the structures below, n and methods for their synthesis, wherein: n R 1 is lower alkyl, benzyl, or substituted benzyl; n X is a suitable leaving group; n Y is an electron withdrawing group that can subsequently be converted into an amino group; n one broken line is present as a carbon—carbon bond and the other broken line is absent, where the broken line forms an unconjugated carbon—carbon double bond, which double bond may be endocyclic whereby n is 3 or the double bond may be exocyclic whereby n is 2.

    专利号:US-2024082118-A1
    优先权日:2021-05-19
    标 题:Topical compositions and methods of preparing the same
    发明人:ABRAMOVICH SAGI; AVIDOR GAL; LANDA BENZION
    权利人:LANDA LABS 2012 LTD
    摘要:There is disclosed a composition comprising a water-insoluble thermoplastic compound capable of stimulating collagen synthesis (CSSC), the CSSC having a molecular weight of more than 0.6 kDa and being dispersed in a polar carrier as nano-elements having an average diameter of 200 nm or less and a viscosity of 107 mPa·s or less. The nano-elements of CSSC can be capable of stimulating the synthesis of skin proteins and/or enabling the delivery of active agents upon their application to a surface to be treated therewith. Methods for preparing the compositions and uses thereof are also provided.

    专利号:US-2014378538-A1
    优先权日:2011-12-14
    标 题:Methods of responding to a biothreat
    发明人:BANCEL STEPHANE
    权利人:MODERMA THERAPEUTICS INC
    摘要:The present disclosure provides for devices, in particular mobile devices, which may be used in the synthesis of modified nucleic acid molecules, in particular modified mRNA molecules. The device for making the modified nucleosides, modified nucleotides and modified nucleic acids (e.g., mRNA) disclosed herein may be mobile devices comprising at least one sample block for insertion of one or more sample vessels, a device base with electronic control units for the sample block, a voltage supply, and one or more reagent(s) for the synthesis of at least one nucleic acid.

    专利号:US-8067465-B2
    优先权日:2002-01-15
    标题:Tricyclic-bis-enone derivatives and methods of use thereof
    发明人:HONDA TADASHI; FAVALORO FRANK G; GRIBBLE GORDON W; SPORN MICHAEL B; SUH NANJOO
    权利人:HONDA TADASHI; FAVALORO FRANK G; GRIBBLE GORDON W; SPORN MICHAEL B; SUH NANJOO; DARTMOUTH COLLEGE
    摘要:Novel tricyclic-bis-enone derivatives (TBEs) as well as the process for the preparation of such TBEs are provided. Also provided are methods for prevention and/or treatment of cancer, Alzheimer's disease, Parkinson's disease, multiple sclerosis, amyotropic lateral sclerosis, rheumatoid arthritis, inflammatory bowel disease, and all other diseases whose pathogenesis is believed to involve excessive production of either nitric oxide (NO) or prostaglandins or the overexpression of iNOS or COX-2 genes or gene products. Further, methods for the synthesis of the TBE compounds of the invention utilize cheap commercially available reagents and are highly cost effective and amenable to scale-up. Additional high efficiency synthetic methods that utilize novel intermediates as well as the synthesis of these intermediates are also provided. Furthermore, the invention also provides methods for designing novel and water-soluble TBEs.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C; Movement Disorder Society Evidence-Based Medicine Committee. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease. Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27372. [Epub ahead of print] Review. doi: 10.1002/14651858.CD000208.pub2. Review. pii: E1192. doi: 10.3390/molecules22071192. Review. doi: 10.1016/j.brainresbull.2017.06.011. Epub 2017 Jun 15. Review. pii: E551. doi: 10.3390/ijms18030551. Review.
    9: Dezsi L, Vecsei L. Monoamine Oxidase B Inhibitors in Parkinson's Disease. CNS Neurol Disord Drug Targets. 2017;16(4):425-439. doi: 10.2174/1871527316666170124165222. Review. doi: 10.1080/17425255.2017.1273901. Epub 2017 Jan 1. Review. eCollection 2016. Review.
    12: Miklya I. The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015). Mol Psychiatry. 2016 Nov;21(11):1499-1503. doi: 10.1038/mp.2016.127. Epub 2016 Aug 2. Review. Epub 2016 Oct 7. Review. doi: 10.1002/14651858.CD007380.pub4. Review. doi: 10.1136/bmjopen-2015-010767. Review. Erratum in: BMJ Open. 2017 Jun 7;7(5):e010767corr1.

    合成参考文献


    参考文献:10.3390/ijms12063648
    摘要:Ashraf MW, Tayyaba S, Afzulpurkar N. Micro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications. Int J Mol Sci. 2011;12(6):3648–704.
    参考文献:10.1007/s00415-011-6163-1
    摘要:Kahraman D, Eggers C, Schicha H, Timmermann L, Schmidt M. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease. J Neurol. 2012 Feb;259(2):251–60. doi: 10.1007/s00415-011-6163-1.
    参考文献:10.2165/11592070-000000000-00000
    摘要:Watkins CC, Pieper AA, Treisman GJ. Safety considerations in drug treatment of depression in HIV-positive patients: an updated review. Drug Saf. 2011 Aug 01;34(8):623–39. doi: 10.2165/11592070-000000000-00000.
    参考文献:10.1007/s10545-011-9375-8
    摘要:Breuer ME, Willems PHGM, Russel FGM, Koopman WJH, Smeitink JAM. Modeling mitochondrial dysfunctions in the brain: from mice to men. J of Inher Metab Disea. 2011 Jul 14;35(2):193–210. doi: 10.1007/s10545-011-9375-8.
    参考文献:10.4103/0019-5545.82567
    摘要:Ramachandraih CT, Subramanyam N, Bar KJ, Baker G, Yeragani VK. Antidepressants: From MAOIs to SSRIs and more. Indian J Psychiatry. 2011 Apr;53(2):180–2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知